Genzyme ^Companies

Coave Therapeutics is a clinical stage biotechnology company that specializes in developing gene therapies for rare ocular and CNS diseases. The company's main goal is to create life-changing treatments for patients suffering from these conditions. Coave Therapeutics has achieved significant milestones, including executing over 15 transactions and forming major industrial partnerships with companies such as Takeda, J&J, BMS, Abbvie, and Nestle Health Sciences. These partnerships have resulted in substantial upfront payments, R&D investments, and equity investments, totaling over €100 million. The team at Coave Therapeutics, led by experienced professionals like Rodolphe and Patricia, is dedicated to advancing the field of gene therapy and improving the lives of patients with rare diseases.